Plain-English translation of NCT07354919 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a medication called to see if it can slow the growth of advanced cancers in people who are already taking opioid pain relievers. The trial will enroll 34 patients with advanced breast, lung, pancreas, or prostate cancer and track whether this medication helps control the cancer, improves bowel function and quality of life, and reduces inflammation in the body.
Many patients with advanced cancer take opioids for pain management, but these medications can cause side effects like constipation and may affect overall health. This trial is exploring whether this medication could address multiple problems at once — potentially slowing cancer growth while also improving bowel function and reducing harmful inflammation.
You likely qualify if…
You likely don't qualify if…
You would take the medication as a daily oral capsule for up to one year (or longer if it seems to be helping you). You'll attend about 10 in-person study visits lasting 1–2 hours each, where you'll have imaging scans, blood draws, physical exams, and answer questions about your symptoms and quality of life. You'll also track your bowel movements daily to help the research team understand how the medication affects your digestive health.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
United States